These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 8219250)
1. Action of "pure" antiestrogens in inhibiting estrogen receptor action. Parker MG Breast Cancer Res Treat; 1993; 26(2):131-7. PubMed ID: 8219250 [TBL] [Abstract][Full Text] [Related]
2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652 [TBL] [Abstract][Full Text] [Related]
3. Pure antiestrogens and breast cancer. Elkak AE; Mokbel K Curr Med Res Opin; 2001; 17(4):282-9. PubMed ID: 11922402 [TBL] [Abstract][Full Text] [Related]
4. Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer. Nicholson RI; Gee JM; Manning DL; Wakeling AE; Montano MM; Katzenellenbogen BS Ann N Y Acad Sci; 1995 Jun; 761():148-63. PubMed ID: 7625718 [No Abstract] [Full Text] [Related]
5. Synthesis and biological activities of thioether derivatives related to the antiestrogens tamoxifen and ICI 164384. Auger S; Mérand Y; Pelletier JD; Poirier D; Labrie F J Steroid Biochem Mol Biol; 1995 Jun; 52(6):547-65. PubMed ID: 7779759 [TBL] [Abstract][Full Text] [Related]
6. 1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonism. von Angerer E; Biberger C; Holler E; Koop R; Leichtl S J Steroid Biochem Mol Biol; 1994 May; 49(1):51-62. PubMed ID: 8003439 [TBL] [Abstract][Full Text] [Related]
7. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569 [TBL] [Abstract][Full Text] [Related]
8. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. Reese JC; Katzenellenbogen BS Nucleic Acids Res; 1991 Dec; 19(23):6595-602. PubMed ID: 1754396 [TBL] [Abstract][Full Text] [Related]
9. Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro. Arbuckle ND; Dauvois S; Parker MG Nucleic Acids Res; 1992 Aug; 20(15):3839-44. PubMed ID: 1508668 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
11. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells. Lazennec G; Katzenellenbogen BS Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022 [TBL] [Abstract][Full Text] [Related]
12. Structure and function of the estrogen receptor. Parker MG; Arbuckle N; Dauvois S; Danielian P; White R Ann N Y Acad Sci; 1993 Jun; 684():119-26. PubMed ID: 8317825 [TBL] [Abstract][Full Text] [Related]
13. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells. Poulin R; Merand Y; Poirier D; Levesque C; Dufour JM; Labrie F Breast Cancer Res Treat; 1989 Oct; 14(1):65-76. PubMed ID: 2605344 [TBL] [Abstract][Full Text] [Related]
14. Antiestrogens activate an estrogen receptor mutant exhibiting enhanced binding to the estrogen response element. Xing H; Haase S; Shapiro DJ Biochem Biophys Res Commun; 1994 Jul; 202(2):888-95. PubMed ID: 8048961 [TBL] [Abstract][Full Text] [Related]
15. Activation of the human estrogen receptor by the antiestrogens ICI 182,780 and tamoxifen in yeast genetic systems: implications for their mechanism of action. Dudley MW; Sheeler CQ; Wang H; Khan S Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3696-701. PubMed ID: 10725345 [TBL] [Abstract][Full Text] [Related]
16. Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology. Lewis DF; Parker MG; King RJ J Steroid Biochem Mol Biol; 1995 Jan; 52(1):55-65. PubMed ID: 7857874 [TBL] [Abstract][Full Text] [Related]
17. Interaction of proteins with transcriptionally active estrogen receptors. Cavaillès V; Dauvois S; Danielian PS; Parker MG Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10009-13. PubMed ID: 7937828 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of low-density lipoprotein oxidation by the pure antiestrogens ICI 182780 and EM-652 (SCH 57068). Hermenegildo C; García-Martínez MC; Tarín JJ; Cano A Menopause; 2002; 9(6):430-5. PubMed ID: 12439102 [TBL] [Abstract][Full Text] [Related]
19. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment. Lykkesfeldt AE; Larsen SS; Briand P Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159 [TBL] [Abstract][Full Text] [Related]
20. Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. Van Den Bemd GJ; Kuiper GG; Pols HA; Van Leeuwen JP Biochem Biophys Res Commun; 1999 Jul; 261(1):1-5. PubMed ID: 10405313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]